Abstract:Cancer treatment has transformed in recent years, with the introduction of immunotherapy providing substantial improvements in prognoses for certain cancers. However, traditional small molecule chemotherapeutics remain as the major frontline of defence, and improving their delivery to solid tumors is of utmost importance for improving potency and reducing side effects. Here, length-controlled one-dimensional seed nanofibers (ca. 25 nm, ĐL = 1.05) were generated from poly(fluorenetrimethylenecarbonate)-b-poly(dimethylaminoethylmethacrylate) via living crystallization-driven self-assembly. Paclitaxel, with an encapsulation content ranging from 1-100 wt%, was loaded onto the preformed nanoparticles by solvent addition and evaporation. Drug loading was quantified by dynamic light scattering and transmission electron microscopy. Drug-loaded vectors were then incubated with U87 MG glioblastoma cells in a 2D cell assay for up to 72 h, and their anticancer properties were determined. It was observed that seed nanofibers loaded with 20 wt% paclitaxel were the most advantageous combination (IC50(nanofiber) = 0.48 μg/mL wherein IC50(paclitaxel) = 0.11 μM), while pure seed nanofibers with no loaded drug displayed much lower cytotoxicity (IC50(nanofiber) = 11.52 μg/mL). The IC50 of the loaded seed nanofibers rivaled that of free paclitaxel (IC50(paclitaxel) = 0.15 μM) as well as the commercially approved Abraxane® (IC50(abraxane) = 0.46 μg/mL wherein IC50(paclitaxel) = 0.06 μM). 3D tumor spheroids were then cultured and subjected to the same stresses. Live/dead cell staining revealed that once more, seed nanofibers with 20 wt% PTX, Abraxane®, and paclitaxel all exhibited similar levels of potency (55% viability), whereas control samples exhibited much higher cell viability (70%) after 3 days. These results demonstrate that nanofibers contain great potential as biocompatible drug delivery vehicles for cancer treatment as they exert a similar anticancer effect to the commercially available Abraxane®.

Paclitaxel-Loaded Silk Fibroin Nanospheres

In Situ Protein-Templated Porous Protein-Hydroxylapatite Nanocomposite Microspheres for Ph-Dependent Sustained Anticancer Drug Release

Facile Preparation of Paclitaxel Loaded Silk Fibroin Nanoparticles for Enhanced Antitumor Efficacy by Locoregional Drug Delivery

Anti-EGFR-iRGD Recombinant Protein Conjugated Silk Fibroin Nanoparticles for Enhanced Tumor Targeting and Antitumor Efficiency

Poly(ether-ester Anhydride)-Based Amphiphilic Block Copolymer Nanoparticle As Delivery Devices for Paclitaxel

Silk Nanofiber Carriers for both Hydrophilic and Hydrophobic Drugs to Achieve Improved Combination Chemotherapy

Size-controllable Dual Drug-Loaded Silk Fibroin Nanospheres Through a Facile Formation Process

Study on the Effect and Mechanism of Paclitaxel-Succini Acid Drug-Loaded Nanofibers in Treating Lung Cancer.

Silk fibroin nanoparticles prepared by electrospray as controlled release carriers of cisplatin.

Development and Characterization of Paclitaxel-Loaded Li-pid-Coated Mesoporous Silica Nanoparticles for Ph-Responsive Tumor-Targeted Drug Delivery

Electrospun Poly(L-Lactide) Nanofibers Loaded with Paclitaxel and Water-Soluble Fullerenes for Drug Delivery and Bioimaging

Self-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinoma

Uniform Block Copolymer Nanofibers for the Delivery of Paclitaxel in 2D and 3D Glioblastoma Tumor Models

Preparation and anti-tumor activity of paclitaxel silk protein nanoparticles encapsulated by biofilm

Electrospun Silk fibroin and Gelatin Blended Nanofibers Functionalized with Noble Metal Nanoparticles for Enhanced Biomedical Applications

Floxuridine-loaded Silk Fibroin Nanospheres

Production of Curcumin-Loaded Silk Fibroin Nanoparticles for Cancer Therapy

Controlled Release of Curcumin and Hypocrellin A from Electrospun Poly(l-Lactic Acid)/Silk Fibroin Nanofibers for Enhanced Cancer Cell Inhibition

Silk fibroin microspheres with photothermal nanocarrier encapsulation for anticancer drug delivery

Electrospun polydioxanone/fucoidan blend nanofibers loaded with anti-cancer precipitate from Jaspis diastra and paclitaxel: Physico-chemical characterization and in-vitro screening

Natural Non-Mulberry Silk Nanoparticles for Potential-Controlled Drug Release